Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2013 | 2 |
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Clin Infect Dis. 2022 Aug 24;75(1):e653-e661. doi: 10.1093/cid/ciac057.
Clin Infect Dis. 2022.
PMID: 35079775
Free PMC article.
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.
Seidel A, Zanoni M, Groß R, Krnavek D, Erdemci-Evin S, von Maltitz P, Albers DPJ, Conzelmann C, Liu S, Weil T, Mayer B, Hoffmann M, Pöhlmann S, Beil A, Kroschel J, Kirchhoff F, Münch J, Müller JA.
Seidel A, et al. Among authors: krnavek d.
Front Immunol. 2022 Jul 25;13:882918. doi: 10.3389/fimmu.2022.882918. eCollection 2022.
Front Immunol. 2022.
PMID: 35958601
Free PMC article.
Item in Clipboard
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
Groß R, Zanoni M, Seidel A, Conzelmann C, Gilg A, Krnavek D, Erdemci-Evin S, Mayer B, Hoffmann M, Pöhlmann S, Liu W, Hahn BH, Beil A, Kroschel J, Jahrsdörfer B, Schrezenmeier H, Kirchhoff F, Münch J, Müller JA.
Groß R, et al. Among authors: krnavek d.
EBioMedicine. 2022 Jan;75:103761. doi: 10.1016/j.ebiom.2021.103761. Epub 2021 Dec 17.
EBioMedicine. 2022.
PMID: 34929493
Free PMC article.
Clinical Trial.
Item in Clipboard
90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
Lodermeyer V, Suhr K, Schrott N, Kolbe C, Stürzel CM, Krnavek D, Münch J, Dietz C, Waldmann T, Kirchhoff F, Goffinet C.
Lodermeyer V, et al. Among authors: krnavek d.
Retrovirology. 2013 Oct 24;10:111. doi: 10.1186/1742-4690-10-111.
Retrovirology. 2013.
PMID: 24156545
Free PMC article.
Item in Clipboard
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.
Yu H, Usmani SM, Borch A, Krämer J, Stürzel CM, Khalid M, Li X, Krnavek D, van der Ende ME, Osterhaus AD, Gruters RA, Kirchhoff F.
Yu H, et al. Among authors: krnavek d.
Retrovirology. 2013 Mar 5;10:27. doi: 10.1186/1742-4690-10-27.
Retrovirology. 2013.
PMID: 23497283
Free PMC article.
Item in Clipboard
An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor.
Venken T, Krnavek D, Münch J, Kirchhoff F, Henklein P, De Maeyer M, Voet A.
Venken T, et al. Among authors: krnavek d.
Proteins. 2011 Nov;79(11):3221-35. doi: 10.1002/prot.23158. Epub 2011 Aug 30.
Proteins. 2011.
PMID: 21989940
Item in Clipboard
Cite
Cite